Related Experiment Video
Updated: May 4, 2026
06:35
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
17.7K
Piezo1: A potential therapeutic target for endothelial dysfunction-related diseases
Xinfei Qiu1, Huini Liu2, Shiqing Yao3
1Nursing College, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Life Sciences
|May 2, 2026
Summary
Piezo1 channels convert mechanical forces into cellular signals. This review explores Piezo1
Area of Science:
- Molecular Biology and Biophysics
- Cardiovascular Physiology
- Cellular Mechanotransduction
Background:
- Mechanotransduction is crucial for cellular signaling, converting physical stimuli into biochemical responses.
- Piezo1, a mechanically activated ion channel, is highly expressed in endothelial cells (ECs) and regulates vascular functions.
- Dysfunctional Piezo1 signaling is linked to various cardiovascular and metabolic diseases.
Purpose of the Study:
- To review the mechanisms of Piezo1 in endothelial dysfunction-related diseases.
- To highlight Piezo1's role in regulating endothelial function.
- To discuss Piezo1 activators and inhibitors as potential therapeutic strategies.
Main Methods:
- Literature review focusing on Piezo1's role in endothelial dysfunction.
- Analysis of studies investigating Piezo1 mechanisms in various pathological conditions.
- Examination of therapeutic approaches targeting Piezo1.
Main Results:
- Piezo1 plays a significant role in physiological processes like vascular tone and barrier maintenance.
- Pathological mechanical forces activate Piezo1, contributing to diseases such as atherosclerosis, hypertension, and diabetes.
- Targeting Piezo1 with activators or inhibitors shows context-dependent effects on endothelial function.
Conclusions:
- Piezo1 is a key regulator of endothelial function and a critical player in endothelial dysfunction-related diseases.
- Modulating Piezo1 activity presents a promising therapeutic avenue for treating conditions like hypertension and atherosclerosis.
- Further research into Piezo1-targeting therapies could lead to novel treatments for cardiovascular and metabolic disorders.
More Related Videos
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
615
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615